664 related articles for article (PubMed ID: 20616683)
1. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
Mezad-Koursh D; Goldstein M; Heilwail G; Zayit-Soudry S; Loewenstein A; Barak A
Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
[TBL] [Abstract][Full Text] [Related]
2. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
[TBL] [Abstract][Full Text] [Related]
4. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
Patel SN; Storey PP; Pancholy M; Obeid A; Wibbelsman TD; Levin H; Hsu J; Garg SJ; Dunn JP; Vander JF
Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
[TBL] [Abstract][Full Text] [Related]
5. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
Busbee BG; Recchia FM; Kaiser R; Nagra P; Rosenblatt B; Pearlman RB
Ophthalmology; 2004 Aug; 111(8):1495-503; discussion 1503. PubMed ID: 15288977
[TBL] [Abstract][Full Text] [Related]
6. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
Dossarps D; Bron AM; Koehrer P; Aho-Glélé LS; Creuzot-Garcher C;
Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
[TBL] [Abstract][Full Text] [Related]
7. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands.
Pijl BJ; Theelen T; Tilanus MA; Rentenaar R; Crama N
Am J Ophthalmol; 2010 Mar; 149(3):482-7.e1-2. PubMed ID: 20053391
[TBL] [Abstract][Full Text] [Related]
8. Endophthalmitis caused by Streptococcus pneumoniae.
Miller JJ; Scott IU; Flynn HW; Smiddy WE; Corey RP; Miller D
Am J Ophthalmol; 2004 Aug; 138(2):231-6. PubMed ID: 15289132
[TBL] [Abstract][Full Text] [Related]
9. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
Lieb DF; Scott IU; Flynn HW; Miller D; Feuer WJ
Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
[TBL] [Abstract][Full Text] [Related]
10. Endogenous endophthalmitis: a 10-year review of culture-positive cases in northern China.
Zhang H; Liu Z
Ocul Immunol Inflamm; 2010 Apr; 18(2):133-8. PubMed ID: 20370344
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
Lima LH; Zweifel SA; Engelbert M; Sorenson JA; Slakter JS; Cooney MJ; Klancnik JM; Yannuzzi LA; Freund KB
Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
[TBL] [Abstract][Full Text] [Related]
12. Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.
Lalwani GA; Flynn HW; Scott IU; Quinn CM; Berrocal AM; Davis JL; Murray TG; Smiddy WE; Miller D
Ophthalmology; 2008 Mar; 115(3):473-6. PubMed ID: 18067969
[TBL] [Abstract][Full Text] [Related]
13. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
[TBL] [Abstract][Full Text] [Related]
14. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.
Hoevenaars NE; Gans D; Missotten T; van Rooij J; Lesaffre E; van Meurs JC
Ophthalmologica; 2012; 228(3):143-7. PubMed ID: 22796790
[TBL] [Abstract][Full Text] [Related]
15. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center.
Moshfeghi AA; Rosenfeld PJ; Flynn HW; Schwartz SG; Davis JL; Murray TG; Smiddy WE; Berrocal AM; Dubovy SR; Lee WH; Albini TA; Lalwani GA; Kovach JL; Puliafito CA
Retina; 2011 Apr; 31(4):662-8. PubMed ID: 21836400
[TBL] [Abstract][Full Text] [Related]
16. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.
Schiedler V; Scott IU; Flynn HW; Davis JL; Benz MS; Miller D
Am J Ophthalmol; 2004 Apr; 137(4):725-31. PubMed ID: 15059712
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.
Modjtahedi BS; Finn AP; Barb SM; MacLachlan MJ; van Zyl T; Papakostas TD; Eliott D
Ophthalmol Retina; 2019 Jan; 3(1):61-72. PubMed ID: 30929817
[TBL] [Abstract][Full Text] [Related]
18. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
Garg SJ; Dollin M; Storey P; Pitcher JD; Fang-Yen NH; Vander J; Hsu J;
Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
[TBL] [Abstract][Full Text] [Related]
19. Endophthalmitis following intravitreal injections.
Irigoyen C; Ziahosseini K; Morphis G; Stappler T; Heimann H
Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):499-505. PubMed ID: 22048244
[TBL] [Abstract][Full Text] [Related]
20. Histopathology of streptococcus mitis/oralis endophthalmitis after intravitreal injection with bevacizumab: a report of 7 patients.
Matthews JL; Dubovy SR; Goldberg RA; Flynn HW
Ophthalmology; 2014 Mar; 121(3):702-8. PubMed ID: 24439760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
